The carnitine system and body composition

Acta Diabetologica

Volumn 40, Issue SUPPL. 1, 2003, Pages

  Reda, E ^a   D'Iddio, S ^a   Nicolai, R ^a   Benatti, P ^a   Calvani, M ^a  

^a Sigma Tau SpA   (Italy)

Author keywords

Carnitine; Insulin resistance; Molecular body composition; Skeletal muscle

Indexed keywords

CARNITINE; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID; INSULIN;

ANIMAL TISSUE; BODY COMPOSITION; CONFERENCE PAPER; CONTROLLED STUDY; FATTY ACID METABOLISM; HOMEOSTASIS; INSULIN RESISTANCE; METABOLIC REGULATION; MUSCLE CONTRACTILITY; MUSCLE METABOLISM; NEUROMUSCULAR SYNAPSE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE;

ANIMALS; BODY COMPOSITION; CARNITINE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MITOCHONDRIA; MODELS, ANIMAL; MUSCLE, SKELETAL; OXIDATION-REDUCTION;

EID: 0142209252     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-003-0040-z     Document Type: Conference Paper

References (84)

1. Fritz IB (1955) The effect of muscle extracts on the oxidation of palmitic acid by liver slices and homogenates. Acta Physiol Scand 34:367-385
2. Fraenkel G, Friedman S (1957) Carnitine. Vitam Horm 15:73-118
3. Bremer J (1962) Carnitine in intermediary metabolism. The metabolism of fatty acid esters of carnitine by mitochondria. J Biol Chem 237:3628-3632
4. Rebouche CJ, Seim H (1998) Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 18:39-61
5. Murthy MSR, Pande SV (1997) Molecular biology of carnitine palmitoyltransferases and role of carnitine in gene transcription. In: de Simone C, Famularo G (eds) Carnitine today. Springer, Berlin Heidelberg New York, pp 39-70
6. Ramsay RR, Gandour RD, van der Leij FR (2001) Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta 1546:21-43
7. Peluso G, Nicolai R, Reda E, Benatti P, Barbarisi A, Calvani M (2000) Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol 182:339-350
8. Ricciolini R, Scalibastri M, Kelleher JK, Carminati P, Calvani M, Arduini A (1998) Role of acetyl-L-carnitine in rat brain lipogenesis: implications for polyunsaturated fatty acid biosynthesis. J Neurochem 71:2510-2517
9. Peluso G, Barbarisi A, Savica V, Reda E, Nicolai R, Benatti P, Calvani M (2001) Carnitine: an osmolyte that plays a metabolic role. J Cell Biochem 80:1-10
10. Peluso G, Petillo O, Barbarisi A, Melone MA, Reda E, Nicolai R, Calvani M (2001) Carnitine protects the molecular chaperone activity of lens alpha-crystallin and decreases the post-translation protein modifications induced by oxidative stress. FASEB J 15:1604-1606
11. Engel AG, Angelini C (1973) Carnitine deficiency of human skeletal muscle with associated lipid storage: a new syndrome. Science 179:899-902
12. Werneck LC, DiMauro S (1985) Muscle carnitine deficiency: report of 8 cases with clinical, electromyographic, histochemical and biochemical studies. Arq Neuropsiquiatr 43:281-295
13. Kimura S, Miyake S (1989) Type II fiber myolysis in a patient with hypocarnitinemia. Brain Dev 11:263-265
14. Miyagawa J, Kuwajima M, Hanafusa T, Ozaki K, Fujimura H, Ono A, Uenaka R, Narama I, Oue T, Yamamoto K, Kaidoh M, Nikaido H, Hayakawa J, Horiuchi M, Saheki T, Matsuzawa Y (1995) Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency. Virchows Arch 426:271-279
15. Hotta K, Kuwajima M, Ono A, Nakajima H, Horikawa Y, Miyagawa J, Namba M, Hanafusa T, Horiuchi M, Nikaido H, Hayakawa J, Saheki T, Kono N, Noguchi T, Matsuzawa Y (1996) Disordered expression of glycolytic and gluconeogenic liver-enzymes of juvenile visceral steatosis mice with systemic carnitine deficiency. Diabetes Res Clin Pract 32:117-123
16. Kaido M, Fujimura H, Ono A, Toyooka K, Yoshikawa H, Nishimura T, Ozaki K, Narama I, Kuwajima M (1997) Mitochondrial abnormalities in a murine model of primary carnitine deficiency. Systemic pathology and trial of replacement therapy. Eur Neurol 38:302-309
17. Kuwajima M, Kono N, Horiuchi M, Imamura Y, Ono A, Inui Y, Kawata S, Koizumi T, Hayakawa JI, Saheki T, Tarui S (1991) Animal model of systemic carnitine deficiency: analysis in C3H-H-2 degrees strain of mouse associated with juvenile visceral steatosis. Biochem Biophys Res Commun 174:1090-1094
18. Nakajima T, Horiuchi M, Yamanaka H, Kizaki Z, Inoue F, Kodo N, Kinugasa A, Saheki T, Sawada T (1997) The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency. Pediatr Res 42:108-113
19. Tomomura M, Nakagawa K, Saheki T (1992) Proto-oncogene c-jun and c-fos messenger RNAs increase in the liver of carnitine-deficient juvenile visceral steatosis (JVS) mice. FEBS Lett 311:63-66
20. Tomomura M, Imamura Y, Horiuchi M, Koizumi T, Nikaido H, Hayakawa J, Saheki T (1992) Abnormal expression of urea cycle enzyme genes in juvenile visceral steatosis (JVS) mice. Biochim Biophys Acta 1138:167-171
21. Musa DMAA, Kobayashi K, Yasuda I, Iijima M, Christoffels VM, Tomomura M, Horiuchi M, Ohnishi T, Kajihara T, Daikuhara Y, Lamers WH, Saheki T (1999) Involvement of a cis-acting element in the suppression of carbamoyl phosphate synthetase I gene expression in the liver of carnitine-deficient mice. Mol Gen Metab 68:346-356
22. Horiuchi M, Kobayashi K, Tomomura M, Kuwajima M, Imamura Y, Koizumi T, Nikaido H, Hayakawa J, Sahek T (1992) Carnitine administration to juvenile visceral steatosis mice corrects the suppressed expression of urea cycle enzymes by normalizing their transcription. J Biol Chem 267:5032-5035
23. Chumlea WC, Guo SS, Vellas B, Guigoz Y (1995) Techniques of assessing muscle mass and function (sarcopenia) for epidemiological studies of the elderly. J Gerontol A Biol Sci Med Sci 50:45-51
24. De Lorenzo A, Sorge RP, Candeloro N, Di Campli C, Sesti G, Lauro R (1999) New insights into body composition assessment in obese women. Can J Physiol Pharmacol 77:17-21
25. Tagliabue A, Andreoli A, Comelli M, Bertoli S, Testolin G, Oriani G, De Lorenzo A (2001) Prediction of lean body mass from multifrequency segmental impedance: influence of adiposity. Acta Diabetol 38:93-97
26. Mingrone G, Bertuzzi A, Capristo E, Greco AV, Manco M, Pietrobelli A, Salinari S, Heymsfield SB (2001) Unreliable use of standard muscle hydration value in obesity. Am J Physiol Endocrinol Metab 280:E365-E371
27. Maiolo C, Mohamed EI, Andreoli A, Candeloro N, Rossi P, De Lorenzo A (2001) Is altered body fat distribution responsible for reduced pulmonary function in obese type 2 diabetic adult women? Diabetes Care 24:961-962
28. Tanaka S, Togashi K, Rankinen T, Perusse L, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C (2002) Is adiposity at normal body weight relevant for cardiovascular disease risk? Int J Obes Relat Metab Disord 26:176-183
29. Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM (2002) Contributions of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab 282:E1023-E1028
30. Mingrone G, Greco AV, Giancaterini A, Scarfone A, Castagneto M, Pugeat M (2002) Sex hormone-binding globulin levels and cardiovascular risk factors in morbidly obese subjects before and after weight reduction induced by diet or malabsorptive surgery. Atherosclerosis 161:455-462
31. Hernandez-Ono A, Monter-Carreola G, Zamora-Gonzalez J, Cardoso-Saldana G, Posadas-Sanchez R, Torres-Tamayo M, Posadas-Romero C (2002) Association of visceral fat with coronary risk factors in a population-based sample of postmenopausal women. Int J Obes Relat Metab Disord 26:33-39
32. Hunt BE, Davy KP, Jones PP, DeSouza CA, Van Pelt RE, Tanaka H, Seals DR (1998) Role of central circulatory factors in the fat-free mass-maximal aerobic capacity relation across age. Am J Physiol 275:H1178-H1182
33. Pahor M, Kritchevsky S (1998) Research hypotheses on muscle wasting, aging, loss of function and disability. J Nutr Health Aging 2:97-100
34. Hansen RD, Raja C, Allen BJ (2000) Total body protein in chronic diseases and in aging. Ann N Y Acad Sci 904:345-352
35. Metter EJ, Talbot LA, Schrager M, Conwit R (2002) Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 57:B359-B365
36. Nourhashemi F, Andrieu S, Gillette-Guyonnet S, Reynish E, Albarede JL, Grandjean H, Vellas B (2002) Is there a relationship between fat-free soft tissue mass and low cognitive function? Results from a study of 7,105 women. J Am Geriatr Soc 50:1796-1801
37. Miyatake N, Fujii M, Nishikawa H, Wada J, Shikata K, Makino H, Kimura I (2000) Clinical evaluation of muscle strength in 20-79-year-old obese Japanese. Diabetes Res Clin Pract 48:15-21
38. Tikkanen HO, Hamalainen E, Sarna S, Adlercreutz H, Harkonen M (1998) Associations between skeletal muscle properties, physical fitness, physical activity and coronary heart disease risk factors in men. Atherosclerosis 137:377-389
39. Vescovo G, Volterrani M, Zennaro R, Sandri M, Ceconi C, Lorusso R, Ferrari R, Ambrosio GB, Dalla Libera L (2000) Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 84:431-437
40. Pu CT, Johnson MT, Forman DE, Hausdorff JM, Roubenoff R, Foldvari M, Fielding RA, Singh MA (2001) Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J Appl Physiol 90:2341-2350
41. Tanner CJ, Barakat HA, Dohm GL, Pories WJ, MacDonald KG, Cunningham PRG, Swanson MS, Houmard JA (2002) Muscle fiber type is associated with obesity and weight loss. Am J Physiol Endocrinol Metab 282:E1191-E1196
42. James DE, Jenkins AB, Kraegen EW (1985) Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. Am J Physiol Endocrinol Metab 248:E567-E574
43. He J, Watkins S, Kelly DE (2001) Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity. Diabetes 50:817-823
44. Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, Haro D (1998) Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 273:8560-8563
45. Louet JF, Hayhurst G, Gonzalez FJ, Girard J, Decaux JF (2002) The coactivator PGC-1 is involved in the regulation of the liver carnitine palmitoyltransferase I gene expression by cAMP in combination with HNF4alpha and cAMP-response element-binding protein (CREB). J Biol Chem 277:37991-38000
46. Jansen MS, Cook GA, Song S, Park EA (2000) Thyroid hormone regulates carnitine palmitoyltransferase I alpha gene expression through elements in the promoter and first intron. J Biol Chem 275:34989-34997
47. Wächter WS, Vogt M, Kreis R, Boesch C, Bigler P, Hoppeler H, Krähenbühl S (2002) Long-term administration of L-carnitine to humans: effect on skeletal muscle carnitine content and physical performance. Clin Chim Acta 318:51-61
48. Hiatt WR, Regensteiner JG, Wolfel EE, Carry MR, Brass EP (1996) Effect of exercise training on skeletal muscle histology and metabolism in peripheral arterial disease. J Appl Physiol 81:780-788
49. McGarry JD (1995) The mitochondrial carnitine palmitoyltransferase system: its broadening role in fuel homeostasis and new insights into its molecular features. Biochem Soc Trans 23:321-324
50. Lee JK, Kim KH (1999) Roles of acetyl-CoA carboxylase beta in muscle cell differentiation and in mitochondrial fatty acid oxidation. Biochem Biophys Res Commun 254:657-660
51. Abu-Elheiga L, Matzuk MM, Abo-Hashema KAH, Wakil SJ (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291:2613-2616
52. Ruderman NB, Saha AK, Vavvas D, Witters LA (1999) Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol 276:E1-E18
53. McGarry JD (2001) Travels with carnitine palmitoyltransferase I: from liver to germ cell with stops in between. Biochem Soc Trans 29:241-245
54. Eaton S (2002) Control of mitochondrial beta-oxidation flux. Progress Lipid Res 41:197-239
55. Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J, McGarry JD (2001) Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 50:123-130
56. Ellis BA, Poynten A, Lowy AJ, Furler SM, Chisholm DJ, Kraegen EW, Cooney GJ (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol Endocrinol Metab 279:E554-E560
57. Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE (1999) Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J 13:2051-2060
58. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA (2000) Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 42:E1039-E1044
59. Colberg SR, Simoneau JA, Thaete FL, Kelley DE (1995) Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest 95:1846-1853
60. Peluso G, Mingrone G, Barbarisi A, Petillo O, Greco AV, Indiveri C, Palmieri F, Reda E, Calvani M (2002) Decreased skeletal muscle carnitine translocase impairs utilization of fatty acids in insulin-resistant human muscle. Front Biosci 7:A109-A116
61. Ferrannini E, Buzzigoli G, Bevilacqua S, Boni C, Del Chiaro D, Oleggini M, Brandi L, Maccari F (1988) Interaction of carnitine with insulin-stimulated glucose metabolism in humans. Am J Physiol 255:946-952
62. De Gaetano A, Mingrone G, Castagneto M, Calvani M (1999) Carnitine increases glucose disposal in humans. J Am Coll Nutr 18:289-295
63. Mingrone G, Greco AV, Capristo E, Benedetti G, Giancaterini A, De Gaetano A, Gasbarrini G (1999) L-carnitine improves glucose disposal in type 2 diabetic patients. J Am Coll Nutr 18:77-82
64. Angelini A, Imparato L, Landi C, Porfido FA, Ciarimboli M, Marro A (1993) Variation in levels of glycaemia and insulin after infusion of glucose solutions with or without added 1-carnitine. Drugs Exp Clin Res 19:219-222
65. Uziel G, Garavaglia B, Di Donato S (1988) Carnitine stimulation of pyruvate dehydrogenase complex (PDHC) in isolated human skeletal muscle mitochondria. Muscle Nerve 11:720-724
66. Capaldo B, Napoli R, Di Bonito P, Albano G, Sacca L (1991) Carnitine improves peripheral glucose disposal in non-insulin-dependent diabetic patients. Diabetes Res Clin Pract 14:191-195
67. Giancaterini A, De Gaetano A, Mingrone G, Gniuli D, Liverani E, Capristo E, Greco AV (2000) Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients. Metabolism 49:704-708
68. Santulli A, Modica A, Curatolo A, d'Amelio V (1988) Carnitine administration to sea bass (dicentrarchus labrax) during feeding on a fat diet: modification of plasma lipid levels and lipoprotein pattern. Aquaculture 68:345-351
69. Owen KQ, Nelssen JL, Goodband RD, Tokach MD, Friesen KG (2001) Effect of dietary L-carnitine on growth performance and body composition in nursery and growing-finishing pigs. J Anim Sci 79:1509-1515
70. Owen KQ, Jit H, Maxwell CV, Nelssen JL, Goodband RD, Tokach MD, Tremblay GC, Koo SI (2001) Dietary L-carnitine suppresses mitochondrial branched-chain keto acid dehydrogenase activity and enhances protein accretion and carcass characteristics of swine. J Anim Sci 79:3104-3112
71. Ji H, Bradley TM, Tremblay GC (1996) Atlantic salmon (Salmo-salar) fed L-carnitine exhibit altered intermediary metabolism and reduced tissue lipid, but no change in growth rate. J Nutr 126:1937-1950
72. Heo K, Lin X, Odle J, Han IK (2000) Kinetics of carnitine palmitoyltransferase-I are altered by dietary variables and suggest a metabolic need for supplemental carnitine in young pigs. J Nutr 130:2467-2470
73. Ricciolini R, Scalibastri M, Carminati P, Arduini A (2001) The effect of pivalate treatment of pregnant rats on body mass and insulin levels in the adult offspring. Life Sci 69:1733-1738
74. Dubelaar ML, Glatz JFC, De Jong YF, Van der Veen FH, Hulsmann WC (1994) Chronic L-carnitine administration combined with minimal electrical stimulation promotes transformation of canine latissimus dorsi muscle. J Appl Physiol 76:1636-1642
75. Pilegaard H, Ordway GA, Saltin B, Neufer PD (2000) Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 279:E806-E814
76. Constantin-Teodosiu D, Howell S, Greenhaff PL (1996) Carnitine metabolism in human muscle fiber types during submaximal dynamic exercise. J Appl Physiol 80:1061-1064
77. Spagnoli LG, Palmieri G, Mauriello A, Vacha GM, D'Iddio S, Giorcelli G, Corsi M (1990) Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle. Nephron 55:16-23
78. Vescovo G, Ravara B, Gobbo V, Sandri M, Angelini A, Della Barbera M, Dona M, Peluso G, Calvani M, Mosconi L, Dalla Libera L (2002) L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am J Physiol Cell Physiol 283:C802-C808
79. De Angelis C, Scarfo C, Falcinelli M, Perna E, Ramacci MT, Angelucci L (1995) Age- and trauma-dependent modifications of neuromuscular junction and skeletal muscle structure in the rat. Effects of long-term treatment with Acetyl-L-carnitine. Mech Ageing Dev 85:37-53
80. De Angelis C, Scarfo C, Falcinelli M, Reda E, Ramacci MT, Angelucci L (1992) Levocarnitine acetyl stimulates peripheral nerve regeneration and neuromuscular junction remodeling following sciatic nerve injury. Int J Clin Pharmacol Res 12:269-279
81. Dubowitz V (1985) Acquired neuropathies, 2nd edn. In: Baillière T (ed) Muscle biopsy: a practical approach. Lavenham, Suffolk, Lavenham Press, pp 246-253
82. Spagnoli LG, Orlandi A, Marino B, Mauriello A, De Angelis C, Ramacci MT (1995) Propionyl-L-carnitine prevents the progression of atherosclerotic lesions in aged hyperlipemic rabbits. Atherosclerosis 114:29-44
83. Orlandi A, Marcellini M, Pesce D, Calvani M, Spagnoli LG (2002) Propionyl-L-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells. Atherosclerosis 160:81-89
84. Kempen KPG, Saris WHM, Kuipers H, Glatz JFC, van der Vusse GJ (1998) Skeletal muscle metabolic characteristics before and after energy restriction in human obesity: fiber type, enzymatic beta-oxidative capacity and fatty acid-binding protein content. Eur J Clin Invest 28:1030-1037